Effect of glucagonlike peptide1 receptor agonists on body weight in adults with obesity without diabetes mellitus—a systematic review and meta‐analysis of …

J Iqbal, HX Wu, N Hu, YH Zhou, L Li, F Xiao… - … Reviews, 2022 - Wiley Online Library
… Clinical trials have investigated the weight loss effect of glucagon-like peptide-1 receptor
agonists (GLP-1 RA) in adults with obesity without diabetes mellitus, but results for weight loss

Weight loss between glucagonlike peptide1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta‐analysis

S Sarma, P Palcu - Obesity, 2022 - Wiley Online Library
… the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, at a dose of 2.4 mg once
weekly, showed weight-loss effectsWeight-lowering effects of GLP-1 receptor agonists have …

The effect of glucagon-like peptide 1 and glucagon-like peptide 1 receptor agonists on energy expenditure: A systematic review and meta-analysis

MG Maciel, BTS Beserra, FCB Oliveira… - Diabetes Research and …, 2018 - Elsevier
glucagon-like peptide-1 receptor agonist” or “GLP-1 receptor agonist” or “GLP-1 analogue”
or “glucagon-like peptide-1 … by weight loss, and this effect may favorably affect weight loss

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

PA Levin, H Nguyen, ET Wittbrodt… - … , metabolic syndrome and …, 2017 - Taylor & Francis
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a … act on the glucagon-like
peptide-1 (GLP-1) receptor on pancreatic … the weight loss with exenatide and the weight gain with …

The impact of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on weight loss following bariatric treatment: a systematic review and meta-analysis

CK Kramer, M Retnakaran… - The Journal of Clinical …, 2024 - academic.oup.com
… Flow diagram of the literature search to identify interventional studies evaluating the effect
of glucagon-like peptide 1 receptor agonists (GLP-1RA) on weight loss following bariatric …

[HTML][HTML] Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: a multivariate meta-analysis

TL Yeh, MC Tsai, WH Tsai, YK Tu, KL Chien - Plos one, 2023 - journals.plos.org
… treatment with a glucagon-like peptide-1 receptor agonist. (lower … treatment with a glucagon-like
peptide-1 receptor agonist. (… in children: Systematic review and meta-analysis. Obesity …

… -loss effect of GLP-1RAs glucagon-like peptide-1 receptor agonists in non-diabetic individuals with overweight or obesity: a systematic review with meta-analysis and …

Y Liu, B Ruan, H Jiang, S Le, Y Liu, X Ao… - The American Journal of …, 2023 - Elsevier
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are … evidence for the effect of
GLP-1RAs on weight loss in a … firm evidence for the overall weight-loss effects of GLP-1RAs. …

[HTML][HTML] … of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis

K Vosoughi, J Atieh, L Khanna, K Khoshbin… - …, 2021 - thelancet.com
… Comparative effectiveness of 7 glucagon-like peptide 1 (GLP-1) agents on weight loss (WL) …
Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials

M Monami, I Dicembrini, B Nreu, F Andreozzi, G Sesti… - Acta Diabetologica, 2017 - Springer
… -analysis is the identification of the characteristics of patients, which predict the efficacy on
HbA1c of glucagon-like peptide-1 receptor agonists (… In fact, weight loss could theoretically …

Efficacy and safety of glucagonlike peptide1 receptor agonists in type 2 diabetes: a systematic review and mixed‐treatment comparison analysis

ZZ Htike, F Zaccardi, D Papamargaritis… - Diabetes, Obesity …, 2017 - Wiley Online Library
effects, particularly weight gain and hypoglycaemia.2 Glucagon-like peptide-1 receptor
agonists (… , with the added benefits of promoting weight loss and low risk of hypoglycaemia.3-6 …